A-Top Health Biotech Co., Ltd. (TPEX:7686)
Taiwan · Delayed Price · Currency is TWD 562.00
-53.00 (-8.62%)
At close: Oct 16, 2026
A-Top Health Biotech Market Cap
A-Top Health Biotech has a market cap or net worth of 28.16 billion as of October 16, 2026. It is the 10,939th most valuable company in the world and the 351st biggest in Taiwan.
Market Cap
28.16B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#351 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 31, 2026, A-Top Health Biotech's market cap has increased from 26.06B to 28.16B, an increase of 8.08%. That is a compound annual growth rate of 85.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 28.16B | -8.62% |
| Oct 15, 2026 | 30.82B | -7.93% |
| Oct 14, 2026 | 33.47B | -4.30% |
| Oct 13, 2026 | 34.98B | -3.06% |
| Oct 12, 2026 | 36.08B | -2.57% |
| Oct 8, 2026 | 37.03B | -0.40% |
| Oct 7, 2026 | 37.18B | -1.85% |
| Oct 6, 2026 | 37.88B | 9.41% |
| Oct 5, 2026 | 34.63B | -2.68% |
| Oct 2, 2026 | 35.58B | -6.58% |
| Oct 1, 2026 | 38.08B | -1.94% |
| Sep 30, 2026 | 38.84B | 0.91% |
| Sep 29, 2026 | 38.48B | 1.86% |
| Sep 24, 2026 | 37.78B | 0.53% |
| Sep 23, 2026 | 37.58B | -6.95% |
| Sep 22, 2026 | 40.39B | -2.42% |
| Sep 21, 2026 | 41.39B | 2.61% |
| Sep 18, 2026 | 40.34B | -7.15% |
| Sep 17, 2026 | 43.45B | -1.14% |
| Sep 16, 2026 | 43.95B | 0.92% |
| Sep 15, 2026 | 43.55B | 0.46% |
| Sep 14, 2026 | 43.35B | 11.90% |
| Sep 11, 2026 | 38.74B | -9.17% |
| Sep 10, 2026 | 42.64B | -4.38% |
| Sep 9, 2026 | 44.60B | -2.52% |
| Sep 8, 2026 | 45.75B | -7.12% |
| Sep 7, 2026 | 49.26B | 22.57% |
| Sep 4, 2026 | 40.19B | 33.67% |
| Sep 3, 2026 | 30.07B | 23.71% |
| Sep 2, 2026 | 24.30B | -3.96% |
| Sep 1, 2026 | 25.31B | -2.88% |
| Aug 31, 2026 | 26.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 55.83B |
| HanchorBio | 22.96B |
| Elixiron Immunotherapeutics (Cayman) Limited | 18.40B |
| Intelligene | 8.70B |
| Obigen Pharma | 8.06B |
| Uwell Biopharma | 6.69B |
| Tripartite Therapeutics | 4.71B |
| Pet Pharm Biotech | 3.08B |